Cold Spring Harbor Laboratory
Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II
Publication
, Preprint
Shamoun, AJ; Reis, G; Ashley, M; Labilloy, A; Ferreira, LF
September 7, 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Shamoun, A. J., Reis, G., Ashley, M., Labilloy, A., & Ferreira, L. F. (2024). Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.09.03.611097
Shamoun, Alex J., Gisienne Reis, Malaica Ashley, Anatalia Labilloy, and Leonardo F. Ferreira. “Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II.” Cold Spring Harbor Laboratory, September 7, 2024. https://doi.org/10.1101/2024.09.03.611097.
Shamoun AJ, Reis G, Ashley M, Labilloy A, Ferreira LF. Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. Cold Spring Harbor Laboratory. 2024.
Shamoun, Alex J., et al. “Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II.” Cold Spring Harbor Laboratory, 7 Sept. 2024. Crossref, doi:10.1101/2024.09.03.611097.
Shamoun AJ, Reis G, Ashley M, Labilloy A, Ferreira LF. Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. Cold Spring Harbor Laboratory. 2024.